Search Results - "KINOSHITA, Takayuki"

RFA experiences, indications and clinical outcomes by Kinoshita, Takayuki

“…Backgound Early-stage breast cancer is increasingly detected by screening mammography, and we aim to establish radiofrequency ablation therapy (RFA) as a…”
Get full text

Novel combination of serum microRNA for detecting breast cancer in the early stage by Shimomura, Akihiko, Shiino, Sho, Kawauchi, Junpei, Takizawa, Satoko, Sakamoto, Hiromi, Matsuzaki, Juntaro, Ono, Makiko, Takeshita, Fumitaka, Niida, Shumpei, Shimizu, Chikako, Fujiwara, Yasuhiro, Kinoshita, Takayuki, Tamura, Kenji, Ochiya, Takahiro

“…MicroRNA (miRNA), which are stably present in serum, have been reported to be potentially useful for detecting cancer. In the present study, we examined the…”
Get full text

Impact of chemotherapy on the association between fear of cancer recurrence and the gut microbiota in breast cancer survivors by Okubo, Ryo, Kinoshita, Takayuki, Katsumata, Noriko, Uezono, Yasuhito, Xiao, Jinzhong, Matsuoka, Yutaka J.

“…•Abundance of the Bacteroides genus is directly related to fear of cancer recurrence.•FCR and Firmicutes phylum are inversely related in those who received…”
Get full text

Prognostic impact of ACTN4 gene copy number alteration in hormone receptor-positive, HER2-negative, node-negative invasive breast carcinoma by Sugano, Teppei, Yoshida, Masayuki, Masuda, Mari, Ono, Makiko, Tamura, Kenji, Kinoshita, Takayuki, Tsuda, Hitoshi, Honda, Kazufumi, Gemma, Akihiko, Yamada, Tesshi

“…Background Most patients with hormone receptor (HR)-positive, human epidermal growth factor receptor type 2 (HER2)-negative breast cancer can be cured by…”
Get full text

Serum miRNA-based Prediction of Axillary Lymph Node Metastasis in Breast Cancer by Shiino, Sho, Matsuzaki, Juntaro, Shimomura, Akihiko, Kawauchi, Junpei, Takizawa, Satoko, Sakamoto, Hiromi, Aoki, Yoshiaki, Yoshida, Masayuki, Tamura, Kenji, Kato, Ken, Kinoshita, Takayuki, Kitagawa, Yuko, Ochiya, Takahiro

“…Sentinel lymph node biopsy (SLNB) is the gold-standard procedure for evaluating axillary lymph node (ALN) status in patients with breast cancer. However, the…”
Get full text

Paclitaxel-induced peripheral neuropathy in patients receiving adjuvant chemotherapy for breast cancer by Tanabe, Yuko, Hashimoto, Kenji, Shimizu, Chikako, Hirakawa, Akihiro, Harano, Kenichi, Yunokawa, Mayu, Yonemori, Kan, Katsumata, Noriyuki, Tamura, Kenji, Ando, Masashi, Kinoshita, Takayuki, Fujiwara, Yasuhiro

“…Background The long-term outcomes and risk factors of paclitaxel-induced peripheral neuropathy (PIPN) have not yet been fully elucidated. Methods We identified…”
Get full text

Comparison of the Indocyanine Green Fluorescence and Blue Dye Methods in Detection of Sentinel Lymph Nodes in Early-stage Breast Cancer by Sugie, Tomoharu, Sawada, Terumasa, Tagaya, Nobumi, Kinoshita, Takayuki, Yamagami, Kazuhiko, Suwa, Hirofumi, Ikeda, Takafumi, Yoshimura, Kenichi, Niimi, Miyuki, Shimizu, Akira, Toi, Masakazu

“…Purpose To assess the diagnostic performance of sentinel lymph node (SLN) biopsy using the indocyanine green (ICG) fluorescence method compared with that using…”
Get full text

Evaluation of sentinel node biopsy by combined fluorescent and dye method and lymph flow for breast cancer by Hojo, Takashi, Nagao, Tomoya, Kikuyama, Mizuho, Akashi, Sadako, Kinoshita, Takayuki

“…Abstract Background Conservative breast resection with subsequent sentinel lymph node biopsy (SNB) is an increasingly popular initial approach for the…”
Get full text

PIK3CA mutation profiling in patients with breast cancer, using a highly sensitive detection system by Shimoi, Tatsunori, Hamada, Akinobu, Yamagishi, Marifu, Hirai, Mitsuharu, Yoshida, Masayuki, Nishikawa, Tadaaki, Sudo, Kazuki, Shimomura, Akihiko, Noguchi, Emi, Yunokawa, Mayu, Yonemori, Kan, Shimizu, Chikako, Kinoshita, Takayuki, Fukuda, Takahiro, Fujiwara, Yasuhiro, Tamura, Kenji

“…PIK3CA mutations are common activating mutations associated with breast cancer (occurring in 20–30% of all cases) and are potent predictive markers for…”
Get full text

Neoadjuvant anastrozole versus tamoxifen in patients receiving goserelin for premenopausal breast cancer (STAGE): a double-blind, randomised phase 3 trial by Masuda, Norikazu, MD, Sagara, Yasuaki, MD, Kinoshita, Takayuki, MD, Iwata, Hiroji, MD, Nakamura, Seigo, Prof, Yanagita, Yasuhiro, MD, Nishimura, Reiki, MD, Iwase, Hirotaka, Prof, Kamigaki, Shunji, MD, Takei, Hiroyuki, MD, Noguchi, Shinzaburo, Prof

“…Summary Background Aromatase inhibitors have shown increased efficacy compared with tamoxifen in postmenopausal early breast cancer. We aimed to assess the…”
Get full text

Chemotherapy resumption in breast cancer patient after COVID-19 by Horiguchi, Julian, Nakashoji, Ayako, Kawahara, Naoki, Matsui, Akira, Kinoshita, Takayuki

“…Background While many studies have verified the effect of recent anti-cancer treatment in patients with COVID-19, there are no data on the optimal time for…”
Get full text

A tissue microRNA signature that predicts the prognosis of breast cancer in young women by Hironaka-Mitsuhashi, Ai, Matsuzaki, Juntaro, Takahashi, Ryou-U, Yoshida, Masayuki, Nezu, Yutaka, Yamamoto, Yusuke, Shiino, Sho, Kinoshita, Takayuki, Ushijima, Toshikazu, Hiraoka, Nobuyoshi, Shimizu, Chikako, Tamura, Kenji, Ochiya, Takahiro

“…Since breast cancers in young women are generally aggressive, young patients tend to be intensively treated with anti-cancer drugs. To optimize the strategy…”
Get full text

Breast cancer survival among Japanese individuals and US residents of Japanese and other origins: a comparative registry-based study by Ogiya, Rin, Niikura, Naoki, Kumamaru, Hiraku, Takeuchi, Yoshinori, Okamura, Takuho, Kinoshita, Takayuki, Aogi, Kenjiro, Anan, Keisei, Iijima, Kotaro, Ishida, Takanori, Iwamoto, Takayuki, Kawai, Masaaki, Kojima, Yasuyuki, Sakatani, Takashi, Sagara, Yasuaki, Hayashi, Naoki, Masuoka, Hideji, Yoshida, Masayuki, Miyata, Hiroaki, Tsuda, Hitoshi, Imoto, Shigeru, Jinno, Hiromitsu

“…Background Breast cancer survival outcomes vary across different ethnic groups. We clarified the differences in clinicopathological and survival…”
Get full text

A prediction model for early systemic recurrence in breast cancer using a molecular diagnostic analysis of sentinel lymph nodes: A large‐scale, multicenter cohort study by Osako, Tomo, Matsuura, Masaaki, Yotsumoto, Daisuke, Takayama, Shin, Kaneko, Koji, Takahashi, Mina, Shimazu, Kenzo, Yoshidome, Katsuhide, Kuraoka, Kazuya, Itakura, Masayuki, Tani, Mayumi, Ishikawa, Takashi, Ohi, Yasuyo, Kinoshita, Takayuki, Sato, Nobuaki, Tsujimoto, Masahiko, Nakamura, Seigo, Tsuda, Hitoshi, Noguchi, Shinzaburo, Akiyama, Futoshi

“…Background The one‐step nucleic acid amplification (OSNA) assay can quantify the cytokeratin 19 messenger RNA copy number as a proxy for sentinel lymph node…”
Get full text

Young adult breast cancer patients have a poor prognosis independent of prognostic clinicopathological factors: a study from the Japanese Breast Cancer Registry by Kataoka, Akemi, Iwamoto, Takayuki, Tokunaga, Eriko, Tomotaki, Ai, Kumamaru, Hiraku, Miyata, Hiroaki, Niikura, Naoki, Kawai, Masaaki, Anan, Keisei, Hayashi, Naoki, Masuda, Shinobu, Tsugawa, Koichiro, Aogi, Kenjiro, Ishida, Takanori, Masuoka, Hideji, Iijima, Kotaro, Kinoshita, Takayuki, Nakamura, Seigo, Tokuda, Yutaka

“…Purpose The aim of this study was to investigate whether young age at onset of breast cancer is an independent prognostic factor in patients from the Japanese…”
Get full text

NONSURGICAL ABLATION THERAPY FOR SMALL BREAST CARCINOMAS by Kinoshita, Takayuki

“…Breast-conserving therapy was introduced in Japan in the 1980s as a local treatment for early-stage disease used under cautiously developed criteria. Its…”
Get more information

The differences in the histological types of breast cancer and the response to neoadjuvant chemotherapy: The relationship between the outcome and the clinicopathological characteristics by Nagao, Tomoya, Kinoshita, Takayuki, Hojo, Takashi, Tsuda, Hitoshi, Tamura, Kenji, Fujiwara, Yasuhiro

“…Abstract Although effective regimens have been established for invasive ductal carcinoma-not otherwise specified (IDC), the efficacy and prognosis of other…”
Get full text

Response to neoadjuvant chemotherapy for breast cancer judged by PERCIST – multicenter study in Japan by Kitajima, Kazuhiro, Nakatani, Koya, Yamaguchi, Kazushige, Nakajo, Masatoyo, Tani, Atsushi, Ishibashi, Mana, Hosoya, Keiko, Morita, Takahiro, Kinoshita, Takayuki, Kaida, Hayato, Miyoshi, Yasuo

“…Purpose The purpose of this study was to evaluate therapeutic response to neoadjuvant chemotherapy (NAC) and predict breast cancer recurrence using Positron…”
Get full text

Intraductal papillomas on core biopsy can be upgraded to malignancy on subsequent excisional biopsy regardless of the presence of atypical features by Shiino, Sho, Tsuda, Hitoshi, Yoshida, Masayuki, Jimbo, Kenjiro, Asaga, Sota, Hojo, Takashi, Kinoshita, Takayuki

“…Intraductal papillary lesions of the breast constitute a heterogeneous entity, including benign intraductal papilloma (IDP) with or without atypia and…”
Get full text

BRCA1 promoter methylation in breast cancer patients is associated with response to olaparib/eribulin combination therapy by Kawachi, Asuka, Yamashita, Satoshi, Okochi-Takada, Eriko, Hirakawa, Akihiro, Tsuda, Hitoshi, Shimomura, Akihiko, Kojima, Yuki, Yonemori, Kan, Fujiwara, Yasuhiro, Kinoshita, Takayuki, Ushijima, Toshikazu, Tamura, Kenji

“…Background A PARP inhibitor is effective in breast cancer patients with BRCA1/2 germline mutations, and in cell lines with BRCA1 promoter methylation. However,…”
Get full text